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Abstract
Background: Lower extremity trauma during earthquakes accounts for the largest burden of disaster-related
injuries. Insufficient pain management is common in resource-limited disaster settings, and regional anesthesia (RA)
may reduce pain in injured patients beyond current standards of care. To date, no controlled trials have been
conducted to evaluate the use of RA for pain management in a disaster setting.
Methods/design: The Regional Anesthesia for Painful Injuries after Disasters (RAPID) study aims to evaluate
whether regional anesthesia (RA), either with or without ultrasound (US) guidance, can reduce pain from
earthquake-related lower limb injuries in a disaster setting. The proposed study is a blinded, randomized controlled
equivalence trial among earthquake victims with serious lower extremity injuries in a resource-limited setting. After
obtaining informed consent, study participants will be randomized in a 1:1:1 allocation to either: standard care
(parenteral morphine at 0.1 mg/kg); standard care plus a landmark-guided fascia iliaca compartment block (FICB); or
standard care plus an US-guided femoral nerve block. General practice humanitarian response providers who have
undergone a focused training in RA will perform nerve blocks with 20 ml 0.5 % levobupivacaine. US sham activities
will be used in the standard care and FICB arms and a normal saline injection will be given to the control group to
blind both participants and nonresearch team providers. The primary outcome measure will be the summed pain
intensity difference calculated using a standard 11-point Numerical Rating Scale reported by patients over 24 h of
follow-up. Secondary outcome measures will include overall analgesic requirements, adverse events, and participant
satisfaction.
Discussion: Given the high burden of lower extremity injuries in the aftermath of earthquakes and the currently
limited treatment options, research into adjuvant interventions for pain management of these injuries is necessary.
While anecdotal reports on the use of RA for patients injured during earthquakes exist, no controlled studies have
been undertaken. If demonstrated to be effective in a disaster setting, RA has the potential to significantly assist in
reducing both acute suffering and long-term complications for survivors of earthquake trauma.
Trial registration: ClinicalTrials.gov (NCT02698228), registered on 16 February 2016.
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Background
Between 1994 and 2013, approximately 7000 natural di-
sasters were reported globally, affecting more than 200
million people and accounting for over one million
deaths. Earthquakes, and their resultant morbidity and
mortality, have increased over time due to population
growth and increasing urbanization. Given these trends,
earthquakes now account for the largest burden of injury
among all types of geophysical disasters [1, 2].
Epidemiologic studies from multiple settings consist-
ently show that trauma sustained during earthquakes
predominantly injures the extremities, with the lower
limbs most commonly affected [3–6]. The high fre-
quency of lower limb trauma during earthquakes makes
interventions directed at the management of these injur-
ies critical [7].
Inadequate pain management due to oligoanalgesia is
common in nondisaster acute care treatment [8–10]. In
the emergency response phase to a natural disaster,
where resources are often constrained, oligoanalgesia is
even more common [11–13]. Standard pain manage-
ment in disaster settings for severe lower limb injuries
includes intramuscular or intravenous injections of nar-
cotic pain medications, with morphine being the recom-
mended agent [14, 15]. However, narcotic medications
may be unavailable in low-income settings, and patients
with trauma may have clinical instability making narcotic
medications less safe to use; both factors can be barriers
to appropriate pain treatment for earthquake victims
[11, 16]. Subsequently, insufficient pain management
can potentiate both short-term and long-term seque-
lae, including immunosuppression, thrombotic compli-
cations, post-traumatic stress disorders, and chronic
pain syndromes, all of which may further increase the
morbidity associated with index injuries [12, 17].
Regional anesthesia (RA) has the potential to address
the suboptimal pain management that often occurs after
earthquakes. RA involves injecting local anesthetic medi-
cations around a nerve in order to block sensation to a
specific anatomic region [18]. Prior studies have demon-
strated that RA to achieve femoral nerve blockade is a
rapid and safe method for pain management of lower
extremity trauma [19–23]. Hospital-based studies have
found RA to be more effective at reducing pain as
compared to narcotics alone in patients with limb in-
juries. However, nearly all studies on RA have been
conducted in high-resource settings, using specially
trained proceduralists, and have enrolled only patients
with simple hip or femoral fractures [24–26]. This
population is not representative of earthquake victims,
who more frequently have complex injuries including
multiple, open fractures and crush mechanisms,
thereby limiting the generalizability of these RA find-
ings to disaster response settings.
RA can be achieved using either anatomic landmark
or ultrasound (US) guidance. Both the anatomically
guided fascia iliaca compartment block (FICB) and the
US-guided femoral nerve block (FNB) primarily target
the femoral nerve, and with injection of an anesthetic
agent can provide analgesia for much of the lower ex-
tremity [18]. A review article concluded that US-guided
nerve blocks have the potential to greatly improve pain
control in disaster settings [17]. However, the published
literature on the use of US-guided RA in disasters is lim-
ited, and no controlled trials have evaluated the effect-
iveness of RA in a disaster context or resource-limited
setting. A few studies have suggested that local
anesthetic injection using US may reduce complication
rates compared to anatomic landmark-guided injection
[27]. However, a systematic review found no evidence
that US-guided RA was more effective than the use of
landmark-guided injections [27]. Furthermore, the
anatomic method does not require investment in costly
US equipment, which may be important in a resource-
limited or disaster setting.
There are anecdotal reports of the use of both anatomic
landmark- and US-guided RA for the treatment of
earthquake-related injuries, suggesting the feasibility of
these modalities in a disaster setting. However, there have
been no randomized controlled trials (RCTs) conducted
to evaluate the effectiveness, safety, or acceptability of RA
in the aftermath of a major earthquake [13, 28, 29]. Given
the burden of disease, consistent patterns of injuries, and
inadequate pain treatment documented in earthquake set-
tings, interventions to address this substantial global
health burden are needed. A rigorous assessment of the
use of RA techniques to address pain management in dis-
aster settings would be useful to inform treatment proto-
cols. To address this current deficit, the Regional
Anesthesia for Painful Injuries after Disasters (RAPID)
study aims to enroll patients in the aftermath of a major
earthquake to determine whether regional anesthesia,
either with or without ultrasound guidance, can reduce
suffering from lower limb injuries, the most common
earthquake-related injury, as compared to current stand-
ard of care for pain control in these settings.
Methods
Design
The RAPID study will be conducted in the aftermath of
a major earthquake to which a Médecins Sans Frontières
(MSF) field hospital is deployed at the request of the
local Ministry of Health (MoH). The study design is a
blinded RCT using an equivalence design. After obtain-
ing informed consent, earthquake victims with serious
lower extremity injuries will be randomized to one of
three study arms. Eligible participants will be random-
ized in a 1:1:1 allocation ratio to either: standard care
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(defined below); standard care plus an anatomic landmark-
guided FICB; or standard care plus an US-guided FNB. The
structure of the study is illustrated in Fig. 1.
Aims
The goal of the RAPID study is to transform the way
that serious injuries are managed after earthquakes and
other disasters by introducing a cost-effective and ana-
tomically appropriate method for pain control. The trial
will enroll patients in the aftermath of a major earth-
quake to determine whether RA, either with or without
US-guidance, can reduce suffering from lower limb in-
juries, as compared to current standard of care for pain
control in these settings. The study will also evaluate if a
Fig. 1 Study flow diagram. Abbreviations: MSF Médecins Sans Frontières
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brief, focused training for international and local gener-
alist health care providers in RA is sufficient for them to
gain competence in the RA procedures.
Setting
As natural disasters can occur anywhere in the world,
the specific geographic location for the RAPID study is
not predetermined. Earthquakes occur with greater fre-
quency in Asia and in the Americas, accounting for
55 % and 21 % of events over the preceding four de-
cades, respectively [1]. As such, these are the most likely
geographic settings for the trial.
The RAPID study will be restricted to low or middle-
income countries (LMICs) as defined by the World Bank
classification system [30]. As 70 % of the nations with
the largest number of major earthquakes over the past
40 years are classified as LMICs, a resource-constrained
setting will enhance the generalizability of the findings
to venues with a higher future probability for such
events [1]. Additionally, trial activities will take place in
an MSF field hospital, which would only be deployed for
a major disaster in a LMIC at the request of the local
MoH.
In addition, this trial will only be conducted after an
earthquake that meets at least one of the four criteria
for a major disaster established by the Center for Re-
search on the Epidemiology of Disasters (CRED): ten or
more people reported killed, 100 or more people re-
ported affected, a declaration of a state of emergency,
and/or a call for international assistance [31]. The deci-
sion as to whether the earthquake meets these criteria
will be made within 24 h of the event, to allow for trial
commencement within 72–96 h of the event (Fig. 2).
Outcome measures
The primary outcome measure will be the summed pain
intensity difference (SPID), a commonly used measure
to assess efficacy of various pain management interven-
tions [25, 32]. While the SPID has not been previously
validated in a post-earthquake setting, it has been used
in a variety of clinical settings around the world. SPID
measures pain over time and controls for both cultural
and individual differences in pain perception and
expression. To calculate the SPID, participants will be
asked to estimate their pain using a standard 11-point
Numerical Rating Scale (NRS) at baseline (prior to treat-
ment) and at set time points over the subsequent 24 h
of follow-up (Fig. 3). The SPID will be calculated as the
area under the curve describing the difference between
current and baseline pain intensity at each time point.
Secondary outcome measures will include analgesic re-
quirements, adverse events and patient satisfaction. An-
algesic requirements will be recorded as the total
amount of analgesic medication received during the full
24 h of patient follow-up. Adverse events (defined as any
untoward medical occurrences in subjects receiving the
investigational therapy) and serious adverse events (de-
fined as any potentially life-threatening or disabling ad-
verse events) will be monitored and recorded through
structured reporting. Patient satisfaction with their over-
all pain management will be assessed via standardized
questionnaires using Likert scales [33, 34].
Study population
Screening
The study population will be comprised of those injured
in association with the earthquake who present for care
of lower limb injuries at the MSF field hospital. Study
personnel will continuously screen all patients present-
ing to the field hospital until the sample size is reached.
Patients meeting all inclusion criteria and no exclusion
criteria will be eligible for enrollment.
Inclusion/exclusion criteria
The RAPID study will include adult patients (18 years or
older) presenting to the MSF field hospital with one or
more lower limb injuries. The trial will exclude patients
with multisystem trauma, severe respiratory distress,
hypotension, altered mental status, active infection at
the sight of injection, known current pregnancy, and
those who are unable to provide informed consent. Pa-
tients with known allergies to local anesthetic agents or
narcotic pain medication, those receiving antithrombotic
therapy or with a preexisting coagulopathy, and those
likely to receive regional anesthesia for alternative rea-
sons within 2 h of screening will also be excluded.
Pre-earthquake disaster 
event 
Training of RAPID study 
personnel  
0 
Time (days)  
Days 0 - 2 
Earthquake disaster 
event occurs 
RAPID Trial coordinators 
determine if study trigger 
criteria are met 
Days 3 - 4 
Trigger criteria met 
RAPID personnel 
deployed to earthquake 
site for study activities 
RAPID personnel enroll ~ 
50% of required sample 
size  
Local practitioners 
trained in procedural 
study methods 
RAPID personnel and 
local trained practitioners 
enroll ~ remainder of  
Days 30 - 45 
Data management, 
processing and feedback 
to RAPID site 
participants 
Fig. 2 Study timeline
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Informed consent
Study personnel, in conjunction with local translators,
will obtain informed consent from all participants prior
to enrollment. Since many study subjects may be
illiterate, an informed consent script will be utilized that
will be read aloud to them and translated into the local
language. Subjects will then be able to consent via either
a signature or a thumbprint on a Written Consent Form,
based on their level of literacy.
Randomization and blinding
Randomization will occur immediately following in-
formed consent attainment. Study subjects will be indi-
vidually allocated in a 1:1:1 parallel format into three
distinct study arms via blocked randomization with six
subjects per block. Allocation will be achieved using
sealed envelopes containing computer-generated and
preprinted randomization assignments with unique pa-
tient identification numbers.
The enrolled participants and the treating health care
teams will be blinded to the patient’s allocation arm
through uniform exposure to US scanning and injection
procedures as outlined below. Only the research team
proceduralist delivering the injection will know the
intervention received by the patient.
Allocation arms
The RAPID trial will have three allocation arms (Fig. 1).
The first arm will serve as the control group in which
participants will receive a standard parenteral injection
of 0.1 mg/kg of morphine either intravenously or intra-
muscularly. Additionally, 5 ml of 0.9 % normal saline
(placebo) will be injected into the subcutaneous tissue of
the anterior proximal thigh by the proceduralist. Con-
current with the normal saline injection, the US probe
will be placed on the patient’s thigh in close proximity to
the injection site in order to facilitate blinding.
The second arm will receive the standard 0.1 mg/kg of
morphine followed by an injection of 20 ml 0.5 % levo-
bupivacaine into the fascia iliaca compartment. In this
arm, the FICB will be performed using standard ana-
tomic landmarks to guide the injection [35]. To achieve
blinding during the anesthetic injection, the US probe
will also be placed on the skin of the thigh in close prox-
imity to the injection.
The third arm of the RAPID trial will involve treatment
with US-guided FNB. In this arm, enrolled participants
will receive the standard 0.1 mg/kg of morphine followed
by an injection of 20 ml 0.5 % levobupivacaine around
their femoral nerve under direct US-guidance [35].
All patients enrolled in the study, regardless of treat-
ment arm, will continue to receive standard care for pain
based on the discretion of their treating health care pro-
viders in the field hospital. These providers will not be a
member of the RAPID research team and will be blinded
to the patient’s randomization arm. Enrollment in the
study will not be allowed to delay any additional treat-
ments or interventions deemed necessary by the treating
team.
Research personnel training and deployment
Prior to initiation of the trial, and preceding the earth-
quake event, a cohort of MSF nurses and physicians will
be trained in study procedures via a structured interactive
course. These practitioners will make up the international
portion of the RAPID research team, responsible for data
collection and procedural activities. The training will
cover all study procedures, including both anatomic
landmark- and US-guided femoral nerve blockade for
RA [18, 36]. For each trainee, minimum competence
will be assessed using a didactic knowledge test and
assessment of procedural abilities through direct ob-
servation using phantom training models. All research
team members will participate in an additional and
mandatory Good Clinical Practice (GCP) training.
Within 72–96 h of the earthquake event, members of
the RAPID research team will be deployed alongside the
MSF response team and field hospital to the site of the
disaster. The research team will be divided into shifts, to
facilitate 24-h enrollment; each shift will include, at
Fig. 3 Numerical Rating Scale
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minimum, one data collector, a proceduralist, and a local
translator.
As outlined in Fig. 2, study coordinators will also hold
an onsite procedural training for locally recruited health
care providers, who will take over as the RAPID procedur-
alists during the latter half of the study. These providers
will be trained and assessed onsite using the same
methods as the international portion of the research team.
Data collection
Data collection time points are outlined in Fig. 1. Study
personnel will assess the subject’s pain score and vital
signs at baseline and again at eight predetermined inter-
vals using the 11-point NRS (Fig. 3). Adverse events will
be monitored throughout the follow-up period. Addition-
ally, subject satisfaction with their care and total amount
of required analgesic medications will be assessed at the
conclusion of the study for each participant. Baseline
demographic characteristics and information on mech-
anism of injuries will also be gathered at the time of en-
rollment. As the population being evaluated will be
followed-up for only 24 h at a single study site and will
have substantial physical trauma, it is likely that losses
to follow-up through discharge prior to 24 h or patients
leaving against medical advice will be minimal.
Data management
As the trial site will likely be in a setting lacking consist-
ent access to electricity, data will be collected initially on
preprinted standardized Data Collection Forms. Forms
will be organized based on unique participant identifica-
tion numbers and contain no personal identifiers. After
collection, data will be entered into a password-protected
database using REDCap electronic data capture tools by a
member of the research team and backed up to an exter-
nal encrypted hard drive daily [37]. All data will undergo
subsequent re-entry after the acute response phase to
evaluate for input errors. If a discrepancy between the first
and second entry is found, the entry will be reconciled by
consulting source documents. The original paper versions
of all study documents will be securely stored and access-
ible only by study investigators.
Statistical analysis
Sample size
The sample size for this study uses a framework of an
equivalency trial with parenteral morphine as the stand-
ard of care versus morphine with RA as the novel treat-
ment. The new modality is further divided into two
arms of RA: FICB and US-guided FNB. For the purpose
of this study, a clinically important effect size was de-
fined as a 20 % change in the primary outcome of the
SPID. Based on this assumption, a sample size of 63 pa-
tients per arm provides 90 % power to show equivalence
between each group (e.g. RA administered via FICB as
compared to standard care or RA performed using a
FNB versus standard care), assuming a standard devi-
ation (SD) up to 20, a difference between the SPID
group means of 0 and an equivalence of 13, at a 2.5 %
significance level (one-sided). Allowing for 10 % attri-
tion, the sample size is 69 patients per arm, with 207
participants in total.
Outcome analysis and reporting
The primary outcome variable, SPID, will be calculated
using the pain-intensity difference (PID) at each time
point outlined in Fig. 1, which is the difference between
the patient’s pain level at that time on a standard 0–10
scale and the patient’s baseline pain level [25]. The SPID
will be calculated by summing the pain intensity differ-
ence (PID) at each of the study time points, weighted by
the amount of time since the prior assessment; this ap-
proximates the area under the curve for PID over time.
SPID will also be reported as a percentage of maximum
possible SPID.
Baseline patient characteristics and outcome measures
will be reported using means and standard deviations,
medians and ranges, or proportions as appropriate. Ana-
lysis of variance (ANOVA) and Student’s t test will be
employed to determine differences between study arms
for continuous measures, including the primary outcome
of SPID, and the Fisher’s exact test will be used for dif-
ferences in categorical variables. Two-way ANOVA test-
ing with repeated measures in one factor (time) will be
performed to compare the effect of treatment arm over
time on pain-intensity measures.
Missing data will be handled using multiple-imputation
models and standard error uncertainty estimates in which
missing data will be replaced using summary outcomes
from participants with complete data for each variable of
interest. To assess the robustness of the models, sensitivity
analyses will be performed in which the primary outcome
will be compared with and without those lost to follow-up
included and assumed to have the mean SPID correlating
to the allocation arm of initial randomization.
Prior to trial initiation, a statistical analysis plan with
formalized procedural protocols will be created. Ana-
lyses will be performed using STATA 13.0 (StataCorp
LP, College Station, TX, USA). A p value of less than
0.05 will be considered significant for all analyses. All
data analyses will be coded on program files to allow in-
dependent reproduction of analyses.
Reporting of outcomes will follow the most up-to-date
Consolidated Standards of Reporting Trials (CONSORT)
guidelines as well as the extensions to equivalence trials;
and to nonpharmacological interventions. The collected
data set will also be made available in conjunction with
the associated trial report.
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Safety monitoring
An independent Data Safety Monitoring Board (DSMB)
will review participant safety and efficacy of therapies.
The DSMB will be able to recommend modification if
there is concern over undue risk stemming from adverse
events or other safety concerns. The DSMB will be iden-
tified prior to the start of the study and will be activated
when the trial commences.
All research methods will be specified in Standard Op-
erating Procedures (SOP). An internal study monitor
will be integrated into the research team to assess proto-
col adherence during data collection. Additionally, the
RAPID trial coordinators will be in the field for the
study to ensure safe and ethical conduct.
All patients who are enrolled in the trial will be moni-
tored for adverse events. Monitoring will occur via stan-
dardized assessments at predefined time points throughout
the 24-h follow-up period (Fig. 1). Continuous monitoring
by study personnel will be undertaken for a 30-min period
following the administration of any study treatment
medication to assess for immediate serious adverse
events (SAE).
For the purpose of this study, SAE includes
hemorrhage, allergic reaction, anaphylaxis, hypotension,
respiratory depression, compartment syndrome, intra-
neural injection, local anesthetic systemic toxicity
(LAST), or death. With the occurrence of any SAE,
study personnel will initiate immediate treatment in
conjunction with the participant’s primary health care
team. The onsite coordinator, principle investigators,
and DSMB will be made aware within 24 h of any SAE.
Ethical approval
The RAPID trial has received ethical approval from the
MSF Ethical Review Board (Reference number: 1524).
The trial will be conducted in accordance with the
Declaration of Helsinki, as well as the International
Conference on Harmonization (ICH). Collected data
will not be linked to any individual or personal iden-
tifiers. Confidentiality will be maintained at all levels
of data management.
Within 72 h of the earthquake, the research team will
attempt to identify an ethics committee in the country
in which the disaster occurred, which will be given the
opportunity to review the trial protocol and prior ethical
approvals and recommend any changes deemed neces-
sary. In the absence of a local ethics committee, the re-
search team will attempt to contact the appropriate
department in the local MoH to obtain authorization for
the study prior to beginning recruitment at the MSF
field hospital. Recruitment will not begin until these
local approvals have been obtained. In addition, all at-
tempts will be made to recruit local coinvestigators to
support the management of the research study.
Discussion
Earthquakes cause the greatest burden of injuries among
all natural disasters globally [1, 2]. Studies of injury pat-
terns from earthquakes show that approximately half of
all patients sustain lower extremity injuries [3–6], and
that pain management for these victims is often inad-
equate [11–13]. The shortage of sufficient narcotic
medications in LMIC settings, where the majority of
earthquake injuries occur, further compounds this
problem [16].
While there are reports on the use of RA for pain con-
trol in disaster settings, there have been no controlled
studies evaluating whether RA has added benefit over nar-
cotics alone [13, 29]. This trial will rigorously evaluate the
role of RA and also be the first to assess if a focused train-
ing for generalist health care providers is sufficient to ef-
fectively perform RA in the aftermath of a major disaster.
Given the novelty of this particular research study, as well
as the approach of performing an RCT in the aftermath of
a major disaster, the RAPID trial has the potential to
transform the management of pain in earthquake settings
as well as research in acute disaster settings.
The utility of RA in pain management of lower ex-
tremity trauma in high-income country hospitals is well-
described [24–26]. However, the injury patterns and
clinical parameters of this population are not representa-
tive of a post-earthquake setting, where resources are
often scarce and injuries more complex. Although there
are anecdotal reports on the use of RA from contempor-
ary earthquake events [13, 28, 29], this data is limited
and equipoise exists as to whether RA improves pain
control for lower extremity injuries of disaster victims.
The RAPID study will utilize a blinded RCT equivalence
design to address this patient-centered question. Al-
though a nonrandomized observational study would be
less resource and methodologically intensive, such a de-
sign would likely suffer from confounding as patients
with more serious injuries, who are more likely to ex-
perience adverse events and less likely to achieve ad-
equate pain control, would have a higher probability of
receiving RA. Additionally, as the RAPID study out-
comes include assessments of pain, blinding is crucial in
order to avoid bias due to the placebo effect and, there-
fore, necessitates a controlled trial design.
If the RAPID trial demonstrates the effectiveness of
RA, the findings will provide high-quality evidence to in-
form the management of traumatic injuries in disaster
settings. Studies conducted after contemporary earth-
quakes report oligioanalgesia, both for patients with se-
vere injuries and for those undergoing painful
procedures [11–13, 28]. RA may help reduce pain and
suffering of the large numbers of individuals injured in
major earthquakes annually, while also aiding in the
provision of more definitive treatments of injuries
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through fracture and wound management. Beyond
earthquakes, the medical literature on conflict-associated
injuries also demonstrates high rates of lower limb
trauma, which suggests possible application of the
RAPID findings beyond earthquake settings to those in-
juries sustained during other types of humanitarian
emergencies [17].
The training of international and local generalist
health care providers as proceduralists in the trial will
enhance the external validity of the findings, as the like-
lihood of having access to a large body of specialists
trained in RA techniques in a LMIC disaster setting is
low. In addition, RA can be performed with local anes-
thetics that have a nominal cost per dose to administer,
making it a very cost-effective intervention in even the
most resource-limited settings. If the hypothesis of this
trial is proven, the use of regional anesthesia for painful
injuries after disasters may serve in subsequent disasters
to be both a very cost-effective and locally appropriate
method to improve pain management and reduce long-
term morbidity and post-injury disability [12, 17, 38, 39].
To date, there have been no studies anywhere in the
world evaluating the effectiveness, safety, or acceptability
of RA in the aftermath of a major earthquake. Indeed,
there have been no RCTs evaluating any acute patient-
centered medical intervention in the aftermath of a
major earthquake. Therefore, beyond addressing the im-
mediate need for improved pain management in these
settings, the RAPID study is also pioneering new meth-
odologies in humanitarian and disaster research. Al-
though the evidence base for humanitarian response is
replete with retrospective studies, there is a dearth of
high-level evidence from prospective trials to inform the
care of disaster victims [40]. This deficit results in the
use of data extrapolated from nondisaster populations
and consensus opinions for developing treatment rec-
ommendations in disaster settings [14]. As such, execu-
tion of a rigorous RCT in an acute disaster setting will
serve to improve the current evidence base, future re-
search activities, and subsequent humanitarian response
guidelines.
With the high burden of disease, consistent patterns of
injuries and inadequate pain management documented
in earthquake settings, new interventions to address this
substantial global health problem are needed. The RAPID
study will be the first prospective RCT to evaluate
whether RA administered by generalist health care pro-
viders, either with or without US-guidance, can safely and
effectively reduce suffering and pain from earthquake-
related lower limb injuries in a disaster setting.
Trial status
Ethical approval for the study has been obtained from
the MSF Ethical Review Board and 12 study personnel
from MSF have been trained in the trial SOP. The study
will commence after a major earthquake meeting the cri-
teria outlined above occurs in a LMIC to which MSF
has been asked by local government to deploy a field
hospital.
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